The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Costs and benefits of neurosurgical intervention for infant hydrocephalus in sub-Saharan Africa: Clinical article
Abstract
Object: Evidence from the CURE Children's Hospital of Uganda (CCHU) suggests that treatment for hydrocephalus in infants can be effective and sustainable in a developing country. This model has not been broadly supported or implemented due in part to the absence of data on the economic burden of disease or any assessment of the cost and benefit of treatment. The authors used economic modeling to estimate the annual cost and benefit of treating hydrocephalus in infants at CCHU. These results were then extrapolated to the potential economic impact of treating all cases of hydrocephalus in infants in sub-Saharan Africa (SSA). Methods: The authors conducted a retrospective review of all children initially treated for hydrocephalus at CCHU via endoscopic third ventriculostomy or shunt placement in 2005. A combination of data and explicit assumptions was used to determine the number of times each procedure was performed, the cost of performing each procedure, the number of disability-adjusted life years (DALYs) averted with neurosurgical intervention, and the economic benefit of the treatment. For CCHU and SSA, the cost per DALY averted and the benefit-cost ratio of 1 year's treatment of hydrocephalus in infants were determined. Results: In 2005, 297 patients (median age 4 months) were treated at CCHU. The total cost of neurosurgical intervention was $350,410, and the cost per DALY averted ranged from $59 to $126. The CCHU's economic benefit to Uganda was estimated to be between $3.1 million and $5.2 million using a human capital approach and $4.6 million–$188 million using a value of a statistical life (VSL) approach. The total economic benefit of treating the conservatively estimated 82,000 annual cases of hydrocephalus in infants in SSA ranged from $930 million to $1.6 billion using a human capital approach and $1.4 billion–$56 billion using a VSL approach. The minimum benefit-cost ratio of treating hydrocephalus in infants was estimated to be 7:1. Conclusions: Untreated hydrocephalus in infants exacts an enormous price from SSA. The results of this study suggest that neurosurgical intervention has a cost/DALY averted comparable to other surgical interventions that have been evaluated, as well as a favorable benefit-cost ratio. The prevention and treatment of hydrocephalus in SSA should be recognized as a major public health priority.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The value of a statistical life: A critical review of market estimates throughout the world
Viscusi, W. K., & Aldy, J. E. (2003) · Journal of Risk and Uncertainty · doi:10.1023/a:1025598106257 · Cited by 2,135
Thaver, D., & Zaidi, A. K. M. (2009) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3181958755 · Cited by 292
Cited by
Kahle, K. T., Kulkarni, A. V., Limbrick, D. D., & Warf, B. C. (2016) · The Lancet · doi:10.1016/s0140-6736(15)60694-8 · Cited by 683
Self-citationGlobal hydrocephalus epidemiology and incidence: systematic review and meta-analysis
Dewan, M. C., Rattani, A., Mekary, R., Glancz, L. J., Yunusa, I., Baticulon, R. E., Fieggen, G., Wellons, J. C., Park, K. B., & Warf, B. C. (2019) · Journal of Neurosurgery · doi:10.3171/2017.10.jns17439 · Cited by 432
Self-citationChao, T. E., Sharma, K., Mandigo, M., Hagander, L., Resch, S. C., Weiser, T. G., & Meara, J. G. (2014) · The Lancet Global Health · doi:10.1016/s2214-109x(14)70213-x · Cited by 369
Self-citation
Metadata
- Authors
- Warf, B. C., Alkire, B. C., Bhai, S., Hughes, C., Schiff, S. J., Vincent, J. R., & Meara, J. G.
- Venue
- Journal of Neurosurgery: Pediatrics
- Published
- 2011-11
- Volume
- 8
- Issue
- 5
- Pages
- 509-521
- ISSN
- 1933-0707 (ISSN-L)
- 1933-0715
- OpenAlex
- W1941671720
- Cited by
- 169
- References
- 2
- FWCI
- 3.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Costs and benefits of neurosurgical intervention for infant hydrocephalus in sub-Saharan Africa: Clinical article. https://app.cochat.ai/papers/10.3171/2011.8.peds11163
- The paper
- Warf, B. C., Alkire, B. C., Bhai, S., Hughes, C., Schiff, S. J., Vincent, J. R., & Meara, J. G. (2011). Costs and benefits of neurosurgical intervention for infant hydrocephalus in sub-Saharan Africa: Clinical article. Journal of Neurosurgery: Pediatrics. https://doi.org/10.3171/2011.8.peds11163
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.